Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Covington, LA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Danville, VA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hammond, LA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lebanon, NH
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Manassas, VA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Northridge, CA
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
Acute Myocardial Infarction Clinical Trial
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Spinal Stenosis, Lumbar Region With Neurogenic Claudication Clinical Trial
Assessing Superion Clinical Endpoints vs. Decompression
Status: Enrolling
Updated: 6/6/2017
Spine Institute of Louisiana
mi
from
Shreveport, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Children's Hospital of South Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Lurie Children's Hospital- Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Penn State Children's Hospital
mi
from
Hershey, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Mercy Hospitals and Clinics
mi
from
Kansas City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospitals and Clinics of Minnesota - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Status: Enrolling, Phase
Updated: 12/31/1969
Randall Children's Hospital at Legacy Emanuel
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery
Status: Enrolling, Phase
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC - Hillman Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Stepped Care for Youth Living With HIV
Status: Enrolling
Updated: 12/31/1969
Tulane University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Agnes Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
Greenville Health System Cancer Institute
mi
from
Greenville, SC
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
MPN (Myeloproliferative Neoplasms) Clinical Trial
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Engaging Seronegative Youth to Optimize HIV Prevention Continuum
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atopic Dermatitis (AD) Clinical Trial
Targeted Microbiome Transplant in Atopic Dermatitis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cataract Clinical Trial
Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)
Status: Enrolling
Updated: 12/31/1969
Houston Eye Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Cataract Clinical Trial
Clinical Trial to Evaluate the Model SC9 IOL Compared to the Model LI61SE IOL (Bausch & Lomb)
Status: Enrolling
Updated: 12/31/1969
Shasta Eye Medical Group, Inc.
mi
from
Redding, CA
Click here to add this to my saved trials
Lupus Nephritis Clinical Trial
Dynamic Imaging of Variation in Lupus Nephritis
Status: Enrolling, Phase
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Graft vs. Host Disease Clinical Trial
Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Graft vs. Host Disease Clinical Trial
Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Reproductive Clinical Trial
Stellate Ganglion Blockade in Post-Menopausal Women
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Endocrinology, Rheumatology, Orthopedics / Podiatry, Other Clinical Trial
Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Venetoclax (ABT-199) Added to Ibrutinib in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
Electrical Stimulation for the Treatment of Back Pain Using Peripheral Nerve Stimulation (PNS)
Status: Enrolling
Updated: 12/31/1969
Premier Pain Centers, LLC
mi
from
Shrewsbury, NJ
Click here to add this to my saved trials
Psoriasis Clinical Trial
Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis
Status: Enrolling
Updated: 6/7/2017
Texas Dermatology and Laser Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
Difficult Intravenous Access Clinical Trial
Infra Red Vein Visualization: Efficacy vs. Standard Technique
Status: Enrolling
Updated: 12/31/1969
The Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Reproductive Clinical Trial
A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor
Status: Enrolling, Phase IV
Updated: 12/31/1969
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Lupus Erythematosus, Systemic Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Participants With Active Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Center for Rheumatology, Immunology and Arthritis
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Lupus Erythematosus, Systemic Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Participants With Active Systemic Lupus Erythematosus (SLE)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Precision Research Organization
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Status: Enrolling, Phase
Updated: 3/26/2018
Rush Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Status: Enrolling, Phase
Updated: 3/26/2018
The University of Texas Southwestern Medical Center, Children's Medical Center Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Hemophilia A Clinical Trial
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Status: Enrolling, Phase
Updated: 3/26/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Presurgical Study of Daratumumab (CD38 Antagonist) or JNJ-40346527 in Men With High-Risk Localized Prostate Cancer Followed by Radical Prostatectomy
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Rheumatoid Arthritis Interstitial Lung Disease Clinical Trial
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rheumatoid Arthritis Interstitial Lung Disease Clinical Trial
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Status: Enrolling, Phase II
Updated: 12/31/1969
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
Kinematics in Posterior Cruciate Retaining and Bi-Cruciate Retaining Total Knee Replacements Using Mobile Fluoroscopy
Status: Enrolling
Updated: 6/13/2017
The University of Tennessee
mi
from
Knoxville, TN
Click here to add this to my saved trials
Hematology Clinical Trial
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Children Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Advanced Renal Cell Carcinoma Clinical Trial
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Advanced Renal Cell Carcinoma Clinical Trial
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Advanced Renal Cell Carcinoma Clinical Trial
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Center for Digestive Healthcare
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cardiovascular Diseases Clinical Trial
The Role of the Space Environment on Vascular Endothelial and Smooth Muscle Cell Processes
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Waldenstrom Macroglobulinemia Clinical Trial
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Georgetown University
mi
from
Washington DC,
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide
Status: Enrolling, Phase
Updated: 12/31/1969
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Spinal Cord Injury Clinical Trial
Ventilatory Support to Improve Exercise Training in High Level Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Spaulding Hospital Cambridge
mi
from
Cambridge, MA
Click here to add this to my saved trials
Malignant Neoplasm of Breast Clinical Trial
A Phase II Study of Using Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen (AC) for New Triple-Negative Inflammatory Breast Cancer (TN-IBC)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida (McKnight Brain Institute)
mi
from
Gainesville, FL
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Las Vegas Clinic
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Amyotrophic Lateral Sclerosis Clinical Trial
A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Temple University School of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials